How much funding has Solid Biosciences Inc. raised?

Solid Biosciences Inc. has raised $150.0M in total funding, most recently a Series C round.

Who are Solid Biosciences Inc.'s investors?

Solid Biosciences Inc.'s investors include RA Capital Management, Bain Capital Life Sciences, Deerfield Management, RTW Investments, Foresite Capital, Cormorant Asset Management.

When was Solid Biosciences Inc. founded?

Solid Biosciences Inc. was founded in 2013.

Where is Solid Biosciences Inc. headquartered?

Solid Biosciences Inc. is headquartered in Charlestown, Massachusetts, United States.

What industry is Solid Biosciences Inc. in?

Solid Biosciences Inc. operates in Biotech, Healthcare.

How many employees does Solid Biosciences Inc. have?

Solid Biosciences Inc. has 51-200 employees.

Solid Biosciences Inc.

IPO

Home - Solid Biosciences

Public · Charlestown, United States · Founded 2013 · $150.0M raised

Biotech

Healthcare

Headquarters: Charlestown, Massachusetts
Employees: 51–200
Founded: 2013
Business Model: B2B
Website: solidbio.com

Total Funding: $150.0M
Last Round: $50.0M Series CMar 2017
Rounds: 3
Type: Public

About

Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy. Founded in 2013 after co-founder Ilan Ganot's son was diagnosed with DMD, the company develops AAV-based micro-dystrophin gene therapies and genetic regulator technologies. Its lead program SGT-003 is in active Phase I/II clinical trials.

Summary

Solid Biosciences Inc. is a Biotech company based in Charlestown, United States, founded in 2013. It has raised $150.0M in total across 3 rounds, most recently a $50.0M Series C round in Mar 2017. Investors include RA Capital Management, Bain Capital Life Sciences and Deerfield Management.

LinkedIn X (Twitter)